Recombinant KRT20 anticorps (AA 196-323)

N° du produit ABIN7871712

L’anticorps anti-KRT20 Monoclonal Souris est utilisé pour la détection de KRT20 dans des échantillons de Humain. Il a été validé pour WB et IHC (p).

Aperçu rapide pour Recombinant KRT20 anticorps (AA 196-323) (ABIN7871712)

Antigène: KRT20 (Keratin 20 (KRT20))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT20 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: RKRT20-6536

Détail du produit anti-KRT20 anticorps

Épitope: AA 196-323

Fonction: Recombinant Cytokeratin 20 Antibody / CK20 (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: A portion of amino acids 196-323 was used as the immunogen for the recombinant Cytokeratin 20 antibody.

Isotype: IgG2a, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant Cytokeratin 20 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the recombinant Cytokeratin 20 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur KRT20

Antigène: KRT20 (Keratin 20 (KRT20))

Autre désignation: Cytokeratin 20

Sujet: This MAb recognizes an intermediate filament protein of 46 kDa, identified as cytokeratin 20 (KRT20). KRT20 is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900